Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q35173833)
Watch
English
New chemotherapy agents in veterinary medicine.
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12852240
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12852240%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
review article
1 reference
stated in
Europe PubMed Central
title
New chemotherapy agents in veterinary medicine
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12852240
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12852240%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
main subject
chemotherapy
1 reference
based on heuristic
inferred from title
author
Barbara Kitchell
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12852240
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12852240%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
author name string
Antony S Moore
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12852240
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12852240%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
publication date
1 May 2003
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12852240
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12852240%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
published in
Veterinary Clinics of North America: Small Animal Practice
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12852240
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12852240%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
volume
33
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12852240
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12852240%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
issue
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12852240
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12852240%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
page(s)
629-49, viii
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12852240
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12852240%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
cites work
Measurement and characterization of the denitrosation of tauromustine and related nitrosoureas by glutathione transferases in liver cytosol from various species.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900033-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatotoxicity of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in dogs: The use of serial percutaneous liver biopsies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900033-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lomustine (CCNU) for the treatment of resistant lymphoma in dogs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900033-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The nitrosoureas: carmustine (BCNU) and lomustine (CCNU).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900033-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hematological toxicity and therapeutic efficacy of lomustine in 20 tumor-bearing cats: critical assessment of a practical dosing regimen
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900033-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention--III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900033-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Streptozotocin in the treatment of cancer: phase II study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900033-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pancreatic islet cell carcinoma. II. Results of therapy with streptozotocin in 52 patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900033-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical antitumor activity and toxicity of streptozotocin (NSC-85998)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900033-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Toxicologic evaluation of streptozotocin (NSC 85998) in mice, dogs and monkeys
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900033-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Streptozocin for treatment of pancreatic islet cell tumors in dogs: 17 cases (1989-1999).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900033-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900033-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An investigational new drug treatment program for patients with gemcitabine: results for over 3000 patients with pancreatic carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900033-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Modulation of deoxycytidylate deaminase in intact human leukemia cells. Action of 2',2'-difluorodeoxycytidine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900033-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nucleoside analogues: mechanisms of drug resistance and reversal strategies.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900033-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900033-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
New applications of gemcitabine and future directions in the management of pancreatic cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900033-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900033-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The evolving role of gemcitabine in the management of breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900033-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gemcitabine in hematologic malignancies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900033-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II trial of gemcitabine in patients with pretreated advanced soft tissue sarcomas
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900033-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gemcitabine in soft tissue or bone sarcoma resistant to standard chemotherapy: a phase II study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900033-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gemcitabine modulation of alkylator therapy: a phase I trial of escalating gemcitabine added to fixed doses of ifosfamide and doxorubicin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900033-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Radiation concurrent with gemcitabine for locally advanced head and neck cancer: a phase I trial and intracellular drug incorporation study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900033-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Disposition of gemcitabine in rat and dog after single and multiple dosings
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900033-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pilot study of gemcitabine (10 mg/m(2) per min) and cisplatin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900033-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gemcitabine-cisplatin: a schedule finding study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900033-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Saturation of 2',2'-difluorodeoxycytidine 5'-triphosphate accumulation by mononuclear cells during a phase I trial of gemcitabine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900033-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prolonged infusion of gemcitabine: clinical and pharmacodynamic studies during a phase I trial in relapsed acute myelogenous leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900033-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase I clinical, plasma, and cellular pharmacology study of gemcitabine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900033-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gemcitabine as a Radiosensitizer for Nonresectable Feline Oral Squamous Cell Carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0195-5616%2803%2900033-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0195-5616(03)00033-0
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12852240
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12852240%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
PubMed publication ID
12852240
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12852240
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12852240%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
